Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock for $80 per share in cash, which equates to a total equity value of ...

Stryker (SYK) agreed to acquire medical technology maker Inari Medical (NARI) in an all-cash deal worth roughly $4.9 billion as the company looks to boost its neurovascular and endovascular segments.

Stryker plans to acquire Inari Medical in a deal valued at $4.9 billion and designed to strength its position in the peripheral vascular market. The deal, announced Monday and approved by both ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Stryker acquires Inari Medical for $80/share, valuing the deal at $4.9 billion, expanding its venous thromboembolism portfolio. Mechanical thrombectomy for VTE is a $6 billion US market ...

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...

Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical ...

Inari Medical Inc., one of Orange County’s fastest-growing medical device makers, is being acquired for $4.9 billion by global medical technology company Stryker Corp. Stryker on Jan. 6 announced an ...

Stryker, one of the world’s largest medtech companies, announced on January 28 that it would be selling its Spinal Implants business to ...